| Primary |
| Product Used For Unknown Indication |
52.4% |
| Lower Respiratory Tract Infection |
8.1% |
| Tooth Abscess |
4.8% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Helicobacter Infection |
3.2% |
| Drug Use For Unknown Indication |
2.4% |
| Helicobacter Gastritis |
2.4% |
| Infection |
2.4% |
| Pharyngitis |
2.4% |
| Urinary Tract Infection |
2.4% |
| Bronchitis |
1.6% |
| Chest Infection |
1.6% |
| Cough |
1.6% |
| Dental Care |
1.6% |
| Influenza |
1.6% |
| Oropharyngeal Pain |
1.6% |
| Prophylaxis |
1.6% |
| Pyrexia |
1.6% |
| Respiratory Tract Infection |
1.6% |
| Sinusitis |
1.6% |
|
| Urticaria |
15.5% |
| Vomiting |
11.3% |
| Treatment Failure |
9.9% |
| Nephropathy Toxic |
7.0% |
| Pruritus |
7.0% |
| Pruritus Generalised |
5.6% |
| Rash |
5.6% |
| Hypersensitivity |
4.2% |
| Rash Macular |
4.2% |
| Rash Pruritic |
4.2% |
| Tongue Oedema |
4.2% |
| Drug Hypersensitivity |
2.8% |
| Dyspnoea |
2.8% |
| Insomnia |
2.8% |
| Jaundice |
2.8% |
| Nausea |
2.8% |
| Wheezing |
2.8% |
| Blood Creatinine Increased |
1.4% |
| Colitis Ischaemic |
1.4% |
| Dermatitis |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
61.4% |
| Abscess |
4.3% |
| Meningitis |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Lower Respiratory Tract Infection |
2.9% |
| Helicobacter Infection |
2.1% |
| Helicobacter Pylori Infection |
2.1% |
| Hypertension |
2.1% |
| Respiratory Failure |
2.1% |
| Antibiotic Therapy |
1.4% |
| Arthritis Infective |
1.4% |
| Cellulitis |
1.4% |
| Escherichia Infection |
1.4% |
| Gastrointestinal Motility Disorder |
1.4% |
| Induction Of Anaesthesia |
1.4% |
| Intestinal Perforation |
1.4% |
| Kawasaki's Disease |
1.4% |
| Moraxella Infection |
1.4% |
| Oral Candidiasis |
1.4% |
| Pain |
1.4% |
|
| Urticaria |
13.8% |
| Vomiting |
10.3% |
| Gastrointestinal Hypermotility |
6.9% |
| Pyrexia |
6.9% |
| Tachycardia |
6.9% |
| White Blood Cell Count Increased |
6.9% |
| Clostridium Difficile Infection |
3.4% |
| Diarrhoea |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Ear Infection |
3.4% |
| Foetal Growth Restriction |
3.4% |
| Headache |
3.4% |
| Hepatocellular Injury |
3.4% |
| Mania |
3.4% |
| Maternal Exposure During Pregnancy |
3.4% |
| Myalgia |
3.4% |
| Neuropathy Peripheral |
3.4% |
| Palpitations |
3.4% |
| Premature Baby |
3.4% |
| Pruritus |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.3% |
| Plasma Cell Myeloma |
18.1% |
| Depression |
4.8% |
| Immunodeficiency Common Variable |
4.8% |
| Schizophrenia |
4.8% |
| Myelodysplastic Syndrome |
3.6% |
| Parkinson's Disease |
3.6% |
| Chronic Lymphocytic Leukaemia |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Osteoporosis |
2.4% |
| Spasticity Muscle |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
| 5Q Minus Syndrome |
1.2% |
| Actinic Keratosis |
1.2% |
| Alpha-1 Anti-trypsin Deficiency |
1.2% |
| Basal Cell Carcinoma |
1.2% |
| Bipolar Disorder |
1.2% |
| Breast Cancer Metastatic |
1.2% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.2% |
|
| White Blood Cell Count Decreased |
10.5% |
| Renal Failure Acute |
7.9% |
| Urinary Tract Infection |
7.9% |
| Vomiting |
7.9% |
| Gastrointestinal Disorder |
5.3% |
| Neutropenia |
5.3% |
| Paraesthesia |
5.3% |
| Pneumonia |
5.3% |
| Rash |
5.3% |
| Sinusitis |
5.3% |
| Skin Reaction |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
| Visual Impairment |
5.3% |
| Application Site Swelling |
2.6% |
| Candida Infection |
2.6% |
| Drug Ineffective |
2.6% |
| Dry Skin |
2.6% |
| Epilepsy |
2.6% |
| Gastrointestinal Inflammation |
2.6% |
| Headache |
2.6% |
|
